Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$353,554
+$54,288 QoQ
Shares Held
1,405
+2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#3,471
of 4,153 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Braun-Bostich & Associates Inc. holds $3,399,809 across 6 Drug Manufacturers - General names. ABBV ranks #4 (10.4% of the industry book) .
All Filings in ABBV
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $353,554 | 1,405 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $299,266 | 1,376 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $314,402 | 1,376 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $316,978 | 1,369 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $267,664 | 1,442 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $302,337 | 1,443 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $265,839 | 1,496 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $329,989 | 1,671 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $302,561 | 1,764 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $316,671 | 1,739 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $319,393 | 2,061 | Shares | Sole | 2024-01-29 | |
| 2023-06-30 | $284,953 | 2,115 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $270,291 | 1,696 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $210,577 | 1,303 | Shares | Sole | 2023-02-09 | |
| 2020-09-30 | $211,705 | 2,417 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $435,624 | 4,437 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $334,778 | 4,394 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||